Jim Cramer advises investors to buy Oracle following its post-earnings dip, while suggesting caution on C3.ai’s recent surge. He highlights Oracle’s strong core business despite a missed earnings target, contrasting it with C3.ai’s potentially overvalued AI-driven rally.
Oracle reported slightly weaker-than-expected Q2 earnings and revenue, missing Street consensus estimates. However, the company highlighted record AI demand, fueling significant growth in its cloud infrastructure. Despite the miss, several analysts have raised their price targets for ORCL stock.
Oracle and Vodafone are joining forces to provide businesses with global IoT connectivity powered by Oracle’s Enterprise Communications Platform (ECP). This collaboration utilizes Vodafone’s extensive network reach and Oracle’s industry-leading applications to deliver secure, seamless connectivity and real-time data intelligence for businesses across the globe.
Oracle is making significant strides in the healthcare space, announcing plans to become a Qualified Health Information Network (QHIN) under the Trusted Exchange Framework and Common Agreement (TEFCA). This move, alongside new talent acquisition and supply chain capabilities, aims to enhance data exchange, streamline hiring, and optimize inventory management within the healthcare industry.
Oracle Corporation (ORCL) shares climbed on Thursday after NTT DATA Japan announced its adoption of Oracle Alloy to enhance its sovereign cloud services and provide access to a wide range of Oracle Cloud Infrastructure capabilities. This partnership will accelerate cloud adoption in Japan, while ensuring data sovereignty and compliance.
Oracle Corporation (ORCL) has introduced Oracle Health Clinical Data Exchange, a cloud-based solution designed to simplify and automate medical claims processing. This innovative platform aims to improve efficiency, reduce administrative costs, and ultimately enhance patient care by facilitating secure and automated data exchange between healthcare providers and payers.
Momentum trading involves buying stocks that are on the rise with the expectation that they will continue to climb. This article identifies three stocks that are experiencing strong momentum, supported by strong fundamentals, analyst upgrades, and upcoming catalysts. These include Meta Platforms, Palo Alto Networks, and Oracle, which are all poised to continue their upward trajectory.
Intel is facing a challenging period with its stock plummeting and a potential takeover by Apollo Global Management in the air. Meanwhile, Oracle is making significant strides in AI and cloud computing, investing $6.5 billion in Malaysia to build an AI supercluster. Analyst sentiment favors Oracle with a strong ‘Buy’ consensus and a promising technical outlook, while Intel faces a more cautious outlook. This article delves into the current state of affairs for these two tech giants and their contrasting trajectories.
Elon Musk has expressed admiration for Oracle’s Chief Technology Officer Larry Ellison, highlighting Ellison’s past support and belief in Musk’s endeavors. Ellison has been a vocal supporter of Musk’s work, particularly his success with SpaceX, and even invested $1 billion in Musk’s acquisition of Twitter. This rekindled interest in their relationship showcases their close ties and shared vision for technological innovation.
Oracle’s ambitious plans for an AI supercluster powered by over 130,000 NVIDIA GPUs have led to a scramble for the company’s chips. Even Elon Musk, known for his Tesla and SpaceX ventures, was reportedly at the dinner table “begging” NVIDIA CEO Jensen Huang for more GPUs. The demand for NVIDIA’s AI hardware highlights the company’s dominant position in the market and the growing need for powerful chips to fuel the artificial intelligence revolution.
